Global biotech leaders to gather in Riyadh for RGMBS 2026

Saudi Arabia will host the 4th Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together more than 100 speakers, delegations from 70+ countries and thousands of attendees. The event is designed to advance the kingdom's biotech strategy and its target of adding $34.6 billion in non-oil GDP by 2040.

Why it matters: - RGMBS 2026 is positioned as a core platform for Saudi Arabia's biotech ambitions and its National Biotechnology Strategy. - The summit ties scientific development, investment and workforce building to a stated goal of generating $34.6 billion in non-oil GDP by 2040. - The event could accelerate partnerships, deals and commercialization across the regional biotech ecosystem.

What happened: - The 4th Riyadh Global Medical Biotechnology Summit will take place in Riyadh from Sept. 14-16, 2026. - Organizers expect more than 15,000 visitors, over 100 local and international speakers, 200 biotech and health brands and more than 80 public- and private-sector exhibitors. - Delegations from more than 70 countries are expected to attend. - More than 65 agreements and memorandums of understanding are planned during the summit. - The summit will bring together scientists, investors, government representatives and health innovators.

The details: - The program spans six themes: AI in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and talent development. - The scientific agenda covers the biotech pipeline from population genomics and AI-assisted drug development to local biomanufacturing, regulatory science, commercialization and investment. - The summit is organized under the supervision of the Ministry of National Guard Health Affairs, with support from King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences. - Strategic partners include the Ministry of Investment, Invest Saudi and the Saudi Data and AI Authority. - Prof. Bandar Alknawi, chief executive and president of the Health Affairs of the Ministry of National Guard and KSAU-HS, said this year's theme is "Laying the Foundations for Excellence in Biotechnology." - Alknawi said the summit will highlight global partnerships, including work with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug development. - He said the foundations for a durable biotech ecosystem include advanced labs, research centers, clinical trial networks, biomanufacturing capacity and digital platforms. - He also said investment in national talent and support for researchers are essential to building a sustainable ecosystem.

Between the lines: - Saudi Arabia is using the summit to signal that biotech growth depends on infrastructure, regulation, talent and capital, not just research breakthroughs. - The emphasis on partnerships with top global institutions suggests the kingdom is trying to pair international expertise with local capacity building. - The mix of scientific, investment and policy themes points to a push to turn biotech into an industrial and economic growth sector, not only a health-sector priority.

What's next: - Organizers will move ahead with speaker, exhibitor and delegation planning ahead of the September event. - The summit is likely to be used as a venue for partnership announcements, deal signings and strategy updates tied to Saudi Arabia's biotech roadmap. - Additional information is available by email at PR@legends.sa or by phone at +966 559 810 777.

The bottom line: - RGMBS 2026 is being framed as Saudi Arabia's flagship biotech convening, with the scale, partnerships and policy focus to match the kingdom's long-term bioscience goals.